Moreover, the multivariate analyses also do not confirm the independence of the two genes in predicting prognosis, which may support our hypothesis that a NORAD–PUMILIO–RALGAPB regulatory axis is involved with the tumor phenotype and is impacting patient survival. The gene discussed is NORAD; the disease is neoplasm.